ALXO

ALX Oncology Holdings Inc.

15.89 USD
+0.04 (+0.25%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ALX Oncology Holdings Inc. stock is up 9.74% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 February’s closed higher than January. In the last 5 Unusual Options Trades, there were 4 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
26 Dec 14:57 17 May, 2024 14.00 CALL 80 80
29 Dec 15:52 19 Jan, 2024 14.00 CALL 200 312
08 Jan 16:32 16 Feb, 2024 12.50 PUT 674 29
18 Jan 18:37 17 May, 2024 14.00 CALL 92 80
06 Feb 19:30 16 Aug, 2024 14.00 CALL 83 3

About ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial. ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer.